ProStrakan Group Signed Deal to Purchase Pharmaceuticals Producer in the UK

Font size AAA
14 Jul 2014 13:56 Helen Clark

CHEMMONITOR.COM– ProStrakan Group (the UK), owned by Kyowa Hakko Kirin (KHK), bought UK-based Archimedes Pharma for USD 394 million.

Archimedes Pharma is an international specialty pharmaceutical company providing novel and advanced treatments in the oncology, pain, and critical care sectors throughout Europe. The firm’s leading product is PecFent, which is utilized for managing cancer pain.

03 Feb
Arlanxeo to Start Chloroprene Rubber Capacity Expansion in Q2 2018
03 Feb
Nippon Shokubai to Raise Production Capacities at Three Plants
03 Feb
Grupo Antolín Irausa to Build Three New Plants in the USA
26 Jan
SK Global Chemical Shuts No. 2 Naphtha Cracker in Ulsan
26 Jan
Perlen Packaging to Purchase Stake in Sekoya Indústria e Comércio